Viatris commenced $36.50 per share tender for Pacira BioSciences.
Viatris has formally commenced its tender offer to acquire all outstanding shares of Pacira BioSciences for $36.50 per share in cash.
Capital flows, CMO moves, M&A. Eight editions a day, seven tiers, from the chopped neck.
Fresh today 7 new items in the 18:00 utc editionJump to the new edition ↓Viatris has formally commenced its tender offer to acquire all outstanding shares of Pacira BioSciences for $36.50 per share in cash.
Blackstone Inc. has raised around €13 billion ($14.6 billion) for its European direct lending strategy, showing that institutional investors are still willing to back private credit.
GlobalFoundries has been selected as the technology provider and operator for two new semiconductor fabs in New York under a landmark U.S.-Japan initiative.
CBRE expanded its business delivering the guts of data centers through a $1 billion acquisition, reflecting real estate's growing reliance on the tech cycle.
SkyAI will commence a cash tender offer on October 15, 2026 for up to 95% of its outstanding shares, pre-funded warrants and strategic advisor allocations.
The Indian primary market is gearing up for a busy week, with six mainboard companies scheduled to launch their initial public offerings between October 13 and October 19, 2026.
California voters appear poised to reject Proposition 40, a ballot initiative that would have imposed the nation's first-ever statewide wealth tax on billionaires with net worth over $1 billion.
The branded-identity layer Chiefs of Staff and heritage CMOs route through: your name imprinted on real authorized stock, your pick of 200+ brands and 70,000 products, shipped from one accountable house. Nine editorial desks publish the intelligence those operators read before they sign.